← All trials
NCT03653546
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2018
- Primary completion
- Jun 15, 2021
- Completion date
- Oct 16, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alpha Biopharma (Jiangsu) Co., Ltd.Lead sponsor
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Sungkyunkwan UniversityOverall official - principal investigator
- Shantou UniversityStudy chair
- Shantou UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.